cladribine has been researched along with Benign Neoplasms in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Allen-Philbey, K; Baker, D; De Trane, S; Giovannoni, G; Mateo-Casas, M; Mathews, J; O'Toole, EA; Reyes, S; Schmierer, K; Yildiz, O | 1 |
| Cros-Perrial, E; Dumontet, C; Jordheim, LP; Lefebvre-Tournier, I; Peyrottes, S; Puy, JY | 1 |
| Holmøy, T; Myhr, KM; Torkildsen, Ø | 1 |
| Rommer, PS; Zettl, UK | 1 |
| Bagley, RG; Crawford, J; Krumbholz, R; Kurtzberg, LS; Lovett, D; Roth, S; Rouleau, C; Schmid, S; Teicher, BA; Yao, M | 1 |
| Epner, EM; Phillips, JD; Spurgeon, S; Yu, M | 1 |
| Schmidt, S | 1 |
| Comi, G; Cook, S; Giovannoni, G; Greenberg, SJ; Hamlett, A; Miret, M; Musch, B; Rammohan, K; Rieckmann, P; Sørensen, PS; Vermersch, P; Viglietta, V; Weiner, J | 1 |
| Józefowicz-Okonkwo, G; Robak, T; Szmigielska-Kapłon, A | 1 |
| Hamaki, T; Heike, Y; Hori, A; Kami, M; Kim, SW; Kishi, Y; Kojima, R; Kusumi, E; Masuo, S; Miyakoshi, S; Mori, S; Morinaga, S; Murashige, N; Muto, Y; Takaue, Y; Taniguchi, S; Tanosaki, R; Ueyama, J; Yuji, K | 1 |
| Gojkovic, Z; Hasholt, L; Joergensen, T; Knecht, W; Le Breton, C; Munch-Petersen, B; Piskur, J; Rozpedowska, E; Sandrini, MP; Willer, M | 1 |
| Burris, HA; Eckardt, JR; Fields, S; Kuhn, JG; Rizzo, J; Rodriguez, GI; Smith, LS; VanDenBerg, K; von Hoff, DD; Weiss, GR | 1 |
| Kobayashi, K; O'Brien, SM; Ratain, MJ; Schilsky, RL; Vogelzang, NJ; Vokes, EE | 1 |
| Arnér, E; Brosjö, O; Eriksson, S; Gunvén, P; Julusson, G; Karlsson, A; Liliemark, J; Spasokoukotskaja, T; Wang, L | 1 |
| Csoka, K; de la Torre, M; Fridborg, H; Kristensen, J; Larsson, R; Liliemark, J; Nygren, P | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Copeland, B; Kawasaki, H; Kosty, M; Piro, LD; Saven, A; Waltz, T; Zyroff, J | 1 |
| Block, T; Depenbrock, H; Fellbaum, C; Hanauske, AR; Peter, R; Rastetter, J; Wenger, M | 1 |
| Cheung, WK; Gollard, R; Johannsen, T; Kosty, M; Miller, WE; Moyer, M; Piro, LD; Rose, E; Saven, A; Smith, I | 1 |
| Delannoy, A; Feremans, W; Ferrant, A; Michaux, L; Van Den Neste, E | 1 |
| Cheson, BD | 1 |
| Hutton, JJ; Von Hoff, DD | 1 |
6 review(s) available for cladribine and Benign Neoplasms
| Article | Year |
|---|---|
An update on cladribine for relapsing-remitting multiple sclerosis.
Topics: Administration, Oral; Cladribine; Humans; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-Remitting; Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients.
Topics: Alemtuzumab; Cladribine; Crotonates; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Multiple Sclerosis; Natalizumab; Neoplasms; Nitriles; Toluidines | 2018 |
Cladribine: not just another purine analogue?
Topics: Adenosine Deaminase Inhibitors; Antineoplastic Agents; Autoimmune Diseases; Cladribine; Clinical Trials as Topic; DNA Methylation; Humans; Molecular Structure; Neoplasms; Purines | 2009 |
[Oral cladribine for relapsing-remitting multiple sclerosis: another purine analogue or a genuine therapeutic innovation?].
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Animals; Azathioprine; Cladribine; Clinical Trials, Phase III as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Long-Term Care; Lymphopenia; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neoplasms; Pregnancy; Purine Nucleosides; Randomized Controlled Trials as Topic; Thrombocytopenia | 2010 |
Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy.
Topics: Adenocarcinoma; Burkitt Lymphoma; Cells, Cultured; Cladribine; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukocytes, Mononuclear; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Sarcoma | 1994 |
Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment.
Topics: Antineoplastic Agents; Autoimmunity; Cladribine; Humans; Immunosuppressive Agents; Neoplasms; Neoplasms, Second Primary; Vidarabine | 2001 |
3 trial(s) available for cladribine and Benign Neoplasms
| Article | Year |
|---|---|
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study.
Topics: Administration, Oral; Adult; Cladribine; Disability Evaluation; Double-Blind Method; Europe; Herpes Zoster; Humans; Immunosuppressive Agents; Lymphopenia; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neoplasms; Neurologic Examination; Physical Examination; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Young Adult | 2011 |
A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.
Topics: Adult; Aged; Agranulocytosis; Anemia; Cell Count; Chromatography, High Pressure Liquid; Cladribine; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lymphopenia; Male; Middle Aged; Neoplasms; Neutrophils; Thrombocytopenia | 1995 |
A phase I study of intermittent infusion cladribine in patients with solid tumors.
Topics: Adult; Aged; Blindness; Carcinoma, Non-Small-Cell Lung; Cladribine; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 1994 |
12 other study(ies) available for cladribine and Benign Neoplasms
| Article | Year |
|---|---|
Severe skin reactions associated with cladribine in people with multiple sclerosis.
Topics: Cladribine; Humans; Immunosuppressive Agents; Multiple Sclerosis; Neoplasms; Recurrence | 2020 |
Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Antineoplastic Agents; Arabinonucleosides; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cladribine; Clofarabine; Humans; Limit of Detection; Neoplasms; Polyphosphates; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Vidarabine | 2017 |
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
Topics: Adenine Nucleotides; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Bone Marrow Cells; Cells, Cultured; Cladribine; Clofarabine; Granulocyte-Macrophage Progenitor Cells; HT29 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Models, Biological; Neoplasms; Treatment Outcome; Vidarabine Phosphate; Xenograft Model Antitumor Assays | 2009 |
Cytotoxic effect of cyclosporin A alone and in combination with 2-chlorodeoxyadenosine against P388 murine leukemia in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclosporine; Drug Synergism; Immunosuppressive Agents; Male; Mice; Neoplasm Transplantation; Neoplasms; Purines; Time Factors; Tumor Cells, Cultured | 2002 |
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor.
Topics: Adult; Aged; Antilymphocyte Serum; Bone Marrow Transplantation; Cladribine; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation Immunology; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2004 |
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Cell Line, Tumor; Cladribine; Cytarabine; Directed Molecular Evolution; Drosophila melanogaster; Genes, Transgenic, Suicide; Genetic Therapy; Glioblastoma; Humans; Lethal Dose 50; Mutation; Neoplasms; Osteosarcoma; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Purines; Substrate Specificity; Transduction, Genetic; Vidarabine | 2007 |
In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
Topics: Adrenocortical Carcinoma; Breast Neoplasms; Cladribine; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1994 |
2-Chlorodeoxyadenosine dose escalation in nonhematologic malignancies.
Topics: Adult; Aged; Astrocytoma; Bone Marrow; Brain Neoplasms; Carcinoma, Renal Cell; Cladribine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasms; Nervous System | 1993 |
Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitro.
Topics: Antineoplastic Agents; Cell Division; Cisplatin; Cladribine; Dose-Response Relationship, Drug; Doxorubicin; Drugs, Investigational; Etoposide; Fluorouracil; Humans; Mitomycin; Neoplasms; Neoplastic Stem Cells; Tumor Stem Cell Assay; Vinblastine | 1995 |
Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Biological Availability; Cladribine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia; Male; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome | 1996 |
Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Neoplasms | 1992 |
Cytotoxicity of 2-chlorodeoxyadenosine in a human tumor colony-forming assay.
Topics: Cell Survival; Cells, Cultured; Cladribine; Colony-Forming Units Assay; Deoxyadenosines; Drug Evaluation, Preclinical; Female; Humans; Kinetics; Neoplasms; Vidarabine | 1986 |